Join us as we share how Ocugen is redefining the future of vision through our first-in-class, breakthrough modifier gene therapy platform. Ocugen Chairman, CEO, and Co-Founder, Shankar Musunuri, PhD, MBA, will participate in a fireside chat at the Stifel 2026 Virtual Ophthalmology Forum on Tuesday, May 26, 2026, from 10:30 to 10:55 a.m. EDT. Watch the live webcast here: https://bit.ly/4wETPVB A replay will be available for 30 days following the event. Additional information can be found in the Investors section of our website: https://ir.ocugen.com/ Stifel Financial Corp. #Ocugen #Biotech #GeneTherapy #Ophthalmology #RetinalDiseases #InvestorRelations
